ENSC (NASDAQ:ENSC) is a clinical stage pharmaceutical company dedicated to bringing a novel opioid to the market that resists the addictive properties that have plagued society. Ensysce Biosciences is ...

Ensysce Biosciences (NASDAQ:ENSC) is a clinical stage company that is developing novel opioids that provide the needed pain relief, while greatly limiting the potential for abuse and overdoses that ...

Ensysce Biosciences shares are trading lower by 30% during Thursday's session. The company announced a $5 million registered direct offering and concurrent private placement. Post-Labor Day Trading ...

Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...

(RTTNews) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 07.00 A.M. ET). In the Green Ensysce Biosciences, Inc. (ENSC) is up over 44% at $4.30 Pear ...